Innoviva, Inc.(INVA)- NASDAQ
From other sites
Company Description
Innoviva, Inc. engages in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist (LABA), vilanterol (VI), and an inhaled corticosteroid,... More
Sector: Healthcare
Industry: Biotechnology
Country: United States